Inder Paul Singh, MD, and Thomas Samuelson, MD, presented information on the effectiveness of office-based therapeutics—including SLT and sustained drug delivery—during the ASCRS annual meeting April 25 in Los Angeles.
Zarmeena Vendal, MD, shares insights from a study she presented at the 2025 ASCRS meeting, titled "Clinical Outcomes in Patients with Mild Glaucoma Following Implantation of Violet Light-Filtering, Extended Depth of Focus IOLs."
Hear from Ophthalmology Management chief medical editor Lisa K. Feulner, MD, PhD, as she discusses new cataract and refractive surgery technologies being shown at the 2025 annual meeting of the American Society of Cataract and Refractive Surgery.